Inhibition of α-class cytosolic human carbonic anhydrases I, II, IX and XII, and β-class fungal enzymes by carboxylic acids and their derivatives: New isoform-I selective nanomolar inhibitors
摘要:
The members of a focused series of carboxylic acids and of their derivatives (esters, amides and metal complexes) have been investigated as inhibitors of the main cytosolic/transmembrane carbonic anhydrase isoforms, CA I, II, IX and XII, belonging to the mammalian alpha-class of CAs. These enzymes are present in red blood cells in submillimolar concentration, and typical sulfonamide CA inhibitors do not selectively inhibit any of them. Among such isozymes, the isoform-I is an 'orphan' target that mediates hemorrhagic retinal and cerebral vascular permeability, involved in retinal and cerebral disease. In the present study, we identified the first selective CA I nanomolar inhibitors, that displayed activity against other isozymes in micromolar/millimolar concentration range. Selective CA II over CA I inhibition has also been observed with some diketo acids/metal complexes. Few diketo acid derivatives showed inhibition activities against the fungal beta-class enzymes from Candida albicans and Cryptococcus neoformans in low micromolar concentration range. Prediction of drug-like properties for the most interesting compounds suggests a favorable bioavailability. (C) 2012 Elsevier Ltd. All rights reserved.
Inhibition of α-class cytosolic human carbonic anhydrases I, II, IX and XII, and β-class fungal enzymes by carboxylic acids and their derivatives: New isoform-I selective nanomolar inhibitors
摘要:
The members of a focused series of carboxylic acids and of their derivatives (esters, amides and metal complexes) have been investigated as inhibitors of the main cytosolic/transmembrane carbonic anhydrase isoforms, CA I, II, IX and XII, belonging to the mammalian alpha-class of CAs. These enzymes are present in red blood cells in submillimolar concentration, and typical sulfonamide CA inhibitors do not selectively inhibit any of them. Among such isozymes, the isoform-I is an 'orphan' target that mediates hemorrhagic retinal and cerebral vascular permeability, involved in retinal and cerebral disease. In the present study, we identified the first selective CA I nanomolar inhibitors, that displayed activity against other isozymes in micromolar/millimolar concentration range. Selective CA II over CA I inhibition has also been observed with some diketo acids/metal complexes. Few diketo acid derivatives showed inhibition activities against the fungal beta-class enzymes from Candida albicans and Cryptococcus neoformans in low micromolar concentration range. Prediction of drug-like properties for the most interesting compounds suggests a favorable bioavailability. (C) 2012 Elsevier Ltd. All rights reserved.
Organocatalytic Modified Guareschi–Thorpe Type Regioselective Synthesis: A Unified Direct Access to 5,6,7,8-Tetrahydroquinolines and Other Alicyclic[<i>b</i>]-Fused Pyridines
作者:Pradeep K. Jaiswal、Vashundhra Sharma、Manas Mathur、Sandeep Chaudhary
DOI:10.1021/acs.orglett.8b02132
日期:2018.10.5
An unprecedented organocatalytic, regioselective, modified Guareschi–Thorpe type protocol toward the modular synthesis of 5,6,7,8-tetrahydroquinolines 22a–g and other alicyclic[b]-fused pyridines 23–28 via the identification of Chitosan as a heterogeneous catalyst is reported. This novel strategy is operationally simple and showed a wide range of functional group tolerance and substrate compatibility
前所未有的有机催化,区域选择性,改良的Guareschi-Thorpe型方案,通过鉴定壳聚糖作为多相催化剂,可模块化合成5,6,7,8-四氢喹啉22a – g和其他脂环式[ b ]稠合吡啶23 – 28。被报道。这种新颖的策略操作简单,并且具有广泛的官能团耐受性和底物相容性。拟议的机制途径涉及亚胺-烯胺级联方法,用于合成结构多样的脂环式[ b ]稠合吡啶杂环。新型抗真菌分子的克级合成和鉴定29 –图31强调了这种方法的实用性。